by Scott Larrivee | May 16, 2025 | Podcast
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling...
by Scott Larrivee | Jan 16, 2025 | News
Nusano isotope production to deliver breakthrough, 100X increase in global At-211 supply, and Atley’s radiopharmaceutical manufacturing technology to enable scalable At-211 radiopharmaceutical supply VALENCIA, Calif. and GOTHENBURG, Sweden – Jan. 16, 2025 – Nusano, a...
